$APLS Apellis Pharmaceuticals, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Apellis Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Apellis Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Apellis Pharmaceuticals, Inc. for free.
IRS Number: 271537290
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: APLS
Company Address: 100 FIFTH AVENUE WALTHAM 02451
Phone number: 502-241-4114
Apellis Pharmaceuticals, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 25 2021 | APLS | Apellis Pharmaceut ... | Deschatelets Pascal | Chief Scientific Of ... | Option Exercise | M | 2.67 | 6,250 | 16,688 | 368,999 | |
| Jun 25 2021 | APLS | Apellis Pharmaceut ... | Deschatelets Pascal | Chief Scientific Of ... | Sell | S | 65.61 | 6,250 | 410,063 | 869,587 | 875.8 K to 869.6 K (-0.71 %) |
| Jun 25 2021 | APLS | Apellis Pharmaceut ... | Deschatelets Pascal | Chief Scientific Of ... | Buy | M | 2.67 | 6,250 | 16,688 | 875,837 | 869.6 K to 875.8 K (+0.72 %) |
| Jun 16 2021 | APLS | Apellis Pharmaceut ... | DeLong Mark Jeffrey | Senior Vice Preside ... | Option Exercise | M | 15.52 | 4,000 | 62,080 | 44,000 | |
| Jun 16 2021 | APLS | Apellis Pharmaceut ... | DeLong Mark Jeffrey | Senior Vice Preside ... | Sell | S | 64.96 | 4,000 | 259,830 | 9,490 | 13.5 K to 9.5 K (-29.65 %) |
| Jun 16 2021 | APLS | Apellis Pharmaceut ... | DeLong Mark Jeffrey | Senior Vice Preside ... | Buy | M | 15.52 | 4,000 | 62,080 | 13,490 | 9.5 K to 13.5 K (+42.15 %) |
| Jun 02 2021 | APLS | Apellis Pharmaceut ... | Dunlop A. Sinclair | Director | Buy | J | 0.00 | 2,682 | 0 | 303,361 | 300.7 K to 303.4 K (+0.89 %) |
| Jun 02 2021 | APLS | Apellis Pharmaceut ... | Dunlop A. Sinclair | Director | Buy | J | 0.00 | 13,108 | 0 | 73,108 | 60 K to 73.1 K (+21.85 %) |
| Jun 02 2021 | APLS | Apellis Pharmaceut ... | Dunlop A. Sinclair | Director | Sell | J | 0.00 | 31,855 | 0 | 0 | 31.9 K to 0 (-100.00 %) |
| May 25 2021 | APLS | Apellis Pharmaceut ... | Deschatelets Pascal | Chief Scientific Of ... | Option Exercise | M | 2.67 | 6,250 | 16,688 | 375,249 | |
| May 25 2021 | APLS | Apellis Pharmaceut ... | Deschatelets Pascal | Chief Scientific Of ... | Sell | S | 47.40 | 6,250 | 296,250 | 869,587 | 875.8 K to 869.6 K (-0.71 %) |
| May 25 2021 | APLS | Apellis Pharmaceut ... | Deschatelets Pascal | Chief Scientific Of ... | Buy | M | 2.67 | 6,250 | 16,688 | 875,837 | 869.6 K to 875.8 K (+0.72 %) |
| May 04 2021 | APLS | Apellis Pharmaceut ... | Perry Nicole D | Vice President - Ac ... | Option Exercise | M | 3.76 | 1,000 | 3,760 | 9,161 | |
| May 04 2021 | APLS | Apellis Pharmaceut ... | Perry Nicole D | Vice President - Ac ... | Sell | S | 50.73 | 1,000 | 50,730 | 4,847 | 5.8 K to 4.8 K (-17.10 %) |
| May 04 2021 | APLS | Apellis Pharmaceut ... | Perry Nicole D | Vice President - Ac ... | Buy | M | 3.76 | 1,000 | 3,760 | 5,847 | 4.8 K to 5.8 K (+20.63 %) |
View all Apellis Pharmaceuticals, Inc. insider transactions.